The Josh Carrick Foundation

Lore & Background

Josh Carrick, from Luton, was the son of Steve and Arlene Carrick and the twin brother of Dominic. He was a computer science graduate from the University of Nottingham who was offered his dream job at IBM shortly before his diagnosis. He initially felt a backache in August 2010, attributing it to a long drive. When it did not ease, he had tests which suggested a kidney infection and was prescribed antibiotics, but in September an x-ray diagnosed testicular cancer. Twelve weeks later, after chemotherapy, he was free of symptoms, but by February 2011 they began again. Around Easter it was discovered that the cancer had metastasised to his spine and brain; stronger chemotherapy and a stem cell transplant ended the cancer for a second time. He then had monthly blood tests, and the September one showed that the disease was now incurable. He died in October.

The charity was set up in October 2012, and had raised £50,000 by October 2013. By March 2016 it had raised more than £300,000. It works together with Cancer Research UK, IBM, and the University of Nottingham. IBM offers £100 to the best first-year student in the university's Computer Science department, and offers visits to their laboratories for the top five. The money raised for Cancer Research UK has funded a study on the link between testicular cancer survivors and cardiovascular disease, and a laboratory for a metastasis specialist. A bicycle ride from London to Brighton raised £22,000.

Reader's Guide

The Josh Carrick Foundation is significant as a charity founded by a family in response to a personal tragedy, raising substantial funds for testicular cancer research and awareness. Its partnerships with Cancer Research UK, IBM, and the University of Nottingham illustrate how a small charity can leverage institutional support to fund specific studies, such as the link between testicular cancer survivors and cardiovascular disease, and a laboratory for a metastasis specialist. The foundation also promotes education through IBM's student awards. Recognition by British Prime Minister David Cameron, who awarded Steve and Arlene Carrick the 496th and 497th Points of Light, highlights the charity's impact. Its legacy includes raising over £300,000 by March 2016 and being featured in national newspapers and as the charity of choice at the 2015 RESI Awards.

Josh Carrick's Life and Illness

Josh Carrick grew up in Luton as the son of Steve and Arlene Carrick, sharing a twin bond with his brother Dominic. A computer science graduate from the University of Nottingham, he was on the cusp of what he considered his dream career when tragedy intervened. He had just been offered a position at IBM when a persistent backache, first noticed in August 2010 after a long drive, refused to fade. Initial tests pointed toward a kidney infection, and antibiotics were prescribed, but by September an x-ray revealed testicular cancer. After twelve weeks of chemotherapy, he was symptom-free, offering a glimmer of hope. Yet by February 2011 the symptoms resurfaced, and around Easter the devastating discovery came that the cancer had spread to his spine and brain. A more aggressive chemotherapy regimen followed by a stem cell transplant cleared the disease a second time. Monthly blood tests then became his routine, until the September result confirmed the illness was no longer treatable. He passed away in October 2011, just twenty-three years old.

Establishment and Fundraising Growth

The Josh Carrick Foundation was established in October 2012 by Steve and Arlene Carrick, one year after losing their son, to channel their grief into a British charity focused on testicular cancer awareness and funding research into better treatments. The family's determination translated quickly into tangible results. Within its first year, the foundation had gathered fifty thousand pounds, and by March 2016 that figure had grown to more than three hundred thousand. Among the most memorable fundraising efforts was a bicycle ride from London to Brighton, which alone brought in twenty-two thousand pounds. The charity's mission is twofold: raising public awareness of a disease that often strikes young men in their early twenties, and directing substantial funds toward the scientific research needed to improve outcomes. What began as a small, personal tribute to a twenty-three-year-old from Luton has grown into a meaningful force in the fight against testicular cancer, sustained by the ongoing commitment of the Carrick family and a growing community of supporters.

Partnerships and Research Impact

The foundation's impact extends well beyond awareness campaigns, as it has forged meaningful partnerships with Cancer Research UK, IBM, and the University of Nottingham. Through its collaboration with Cancer Research UK, the charity's fundraising has directly supported a study examining the connection between testicular cancer survivors and cardiovascular disease, as well as the establishment of a dedicated laboratory for a metastasis specialist. The IBM connection carries a personal resonance, given that Josh himself had been offered a role at the company just before his diagnosis. In his memory, IBM now contributes one hundred pounds to the top-performing first-year student in the University of Nottingham's Computer Science department and extends laboratory visit invitations to the top five students. The University of Nottingham, where Josh completed his degree, serves as the academic anchor for these initiatives. Together, these partnerships create a network that links corporate generosity, academic excellence, and medical research in service of the foundation's core mission.

Recognition and National Profile

The Carrick family's dedication to their son's memory has earned them recognition at the highest levels of British public life. Prime Minister David Cameron personally presented Steve and Arlene Carrick with the 496th and 497th Points of Light, a daily honour awarded to outstanding charity fundraisers across the country. Receiving this award side by side as a couple, each with their own numbered citation, underscored the shared, personal nature of their commitment. The foundation has also received sustained coverage in national newspapers, bringing testicular cancer into wider public conversation. In 2015, it was named the charity of choice at the RESI Awards, a testament to the respect it commands within professional and community circles. These accolades reflect not merely the scale of funds raised but the consistency and heart behind the family's work. From a local tragedy in Luton to national recognition, the foundation's story illustrates how one family's loss can be transformed into a broad, enduring campaign for awareness and research.